Advertisement

Topics

New ANDA Review Pathways: Should You Be A Priority Or Expedited?

12:40 EST 13 Nov 2017 | SCRIP

Amid confusion about multiple priority and expedited pathways for US generic drug applications, industry asks which are a true advantage.

      

Related Stories

 

Original Article: New ANDA Review Pathways: Should You Be A Priority Or Expedited?

NEXT ARTICLE

More From BioPortfolio on "New ANDA Review Pathways: Should You Be A Priority Or Expedited?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...